Brenda Thompson: Daily

As millions seek alternatives to traditional sleep pills, cannabis products are taking over. A #1 ranked gummy reveals the science and trends behind the shift.

Recognized by Gartner, Lambda Supply Chain's AI platform promises to simplify complex logistics and cut costs in an increasingly volatile global market.

UnitedHealth Group posted strong Q1 earnings but is shedding members in a bold pivot, divesting globally to double down on US-based AI and tech innovation.

Fintech firm EBANX is bridging the digital divide, enabling merchants to reach over a billion consumers in emerging markets without credit cards.

The 15-year partnership between Kia and TotalEnergies is renewed, focusing on cutting-edge lubricants and solutions for the growing EV market.

Fintech firm OwlTing gets a major vote of confidence as SBI Holdings and legacy shareholders extend their lock-up, aiming to stabilize the stock.

PeptiDream and Asahi Kasei's novel drug candidate, AK1940, begins Phase 1 trials, aiming for a safer, more targeted approach to treating autoimmune diseases.

The fintech firm spins out from its parent, lowering credit score requirements and promising zero-day closings in a bold move to unlock home equity.

Karsan's autonomous e-ATAK has completed commercial service in a ski resort, proving its mettle against snow, ice, and skiers in a major leap for AI.

Notable Capital's inaugural 'Prosumer AI 40' list spotlights the tools giving individuals the power of entire teams, defining a new era of work.

Specialist travel firm Stage and Screen consolidates its brand, leveraging parent Flight Centre's power to dominate the booming sports and entertainment market.

The wellness company faces a tough year with an 8.3% sales drop, operational missteps, and mounting questions about its financial stability.

The $4.1 trillion U.S. Latino economy is being leveraged to tackle energy costs, infrastructure challenges, and the soaring demands of AI technology.

Dr. Jennifer Shuford, a crisis-tested leader from Texas, is named CDC Deputy Director, a move experts hope will stabilize the beleaguered agency.

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

A new global olive leader, Arvos, unites producers from four nations, aiming to simplify retail and dominate the growing chilled Mediterranean food market.

A Korean biotech unveils a breakthrough by targeting the tumor's protective environment, a move that could make existing cancer drugs effective again.

Following its Vacasa acquisition, Casago bets on local franchisees in Boise and McCall to fix industry woes and boost community-focused tourism.

Forget manual inputs. TuMeke's AI now fully automates ergonomic reviews, analyzing force, repetition, and balance to predict and prevent injuries.

Beyond beaches and business, a new conference is rebranding Bermuda as a global hub for creativity, collaboration, and next-generation thought leadership.